Skip to main content

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q4 2025

Institutional positions in Intra-Cellular Therapies, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ITCI is no longer listed, and 13F filings after Q1 2025 list far fewer holders. See Q1 2025

Institutional holders
1
0 vs. Q3 2025
Shares held
1
0 (0.0%) vs. Q3 2025
Total value
$2.54K
$0 (0.0%) vs. Q3 2025
New holders
0
0 more added
Sold out
0
0 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 1 institution
Q1 2021: 170 institutionsQ2 2021: 187 institutionsQ3 2021: 181 institutionsQ4 2021: 208 institutionsQ1 2022: 241 institutionsQ2 2022: 266 institutionsQ3 2022: 274 institutionsQ4 2022: 283 institutionsQ1 2023: 274 institutionsQ2 2023: 288 institutionsQ3 2023: 294 institutionsQ4 2023: 335 institutionsQ1 2024: 346 institutionsQ2 2024: 376 institutionsQ3 2024: 356 institutionsQ4 2024: 387 institutionsQ1 2025: 395 institutionsQ2 2025: 4 institutionsQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2025: $2.54K
Q1 2021: $2.30BQ2 2021: $2.74BQ3 2021: $2.56BQ4 2021: $3.60BQ1 2022: $4.94BQ2 2022: $4.65BQ3 2022: $3.89BQ4 2022: $4.41BQ1 2023: $4.55BQ2 2023: $5.34BQ3 2023: $4.54BQ4 2023: $6.42BQ1 2024: $6.15BQ2 2024: $6.62BQ3 2024: $7.12BQ4 2024: $8.08BQ1 2025: $13.6BQ2 2025: $4.15MQ3 2025: $2.54KQ4 2025: $2.54KQ1 2026: $2.54KQ2 2026: $2.54K
Institutions holding ITCI and their total value by quarter
QuarterHoldersValue
Q2 20261$2.54K
Q1 20261$2.54K
Q4 20251$2.54K
Q3 20251$2.54K
Q2 20254$4.15M
Q1 2025395$13.6B
Q4 2024387$8.08B
Q3 2024356$7.12B
Q2 2024376$6.62B
Q1 2024346$6.15B
Q4 2023335$6.42B
Q3 2023294$4.54B
Q2 2023288$5.34B
Q1 2023274$4.55B
Q4 2022283$4.41B
Q3 2022274$3.89B
Q2 2022266$4.65B
Q1 2022241$4.94B
Q4 2021208$3.60B
Q3 2021181$2.56B
Q2 2021187$2.74B
Q1 2021170$2.30B

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q3 2025.

Institutions holding ITCI in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Huntington National Bank1$2.54K0.00%00.0%Unchanged